Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings

Outcomes of tailoring statin-type based on solute carrier organic anion transporterfamily member 1B1 ( SLCO1B1)pharmacogenetic toxicity information on patient, provider, and pharmacological outcomes are unknown. The trial randomized 159 patients not taking statins because of prior statin myalgia 1:1...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation. Genomic and precision medicine 2018-09, Vol.11 (9), p.e002228-e002228
Hauptverfasser:	Peyser, Bruce, Perry, Emily P, Singh, Kavisha, Gill, Rosalynn D, Mehan, Michael R, Haga, Susanne B, Musty, Michael D, Milazzo, Nicholas A, Savard, Dillon, Li, Yi-Ju, Trujilio, Gloria, Voora, Deepak
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!